Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis.

@article{Klein2011VaginalMP,
  title={Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis.},
  author={Katharina Christiane Klein and Line Rode and Kypros H. Nicolaides and Elisabeth Krampl-Bettelheim and Ann Tabor},
  journal={Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology},
  year={2011},
  volume={38 3},
  pages={281-7}
}
OBJECTIVES Progesterone treatment reduces the risk of preterm delivery in high-risk singleton pregnancies. Our aim was to evaluate the preventive effect of vaginal progesterone in high-risk twins. METHODS This was a subanalysis of a Danish-Austrian, double-blind, placebo-controlled, randomized trial (PREDICT study), in which women with twin pregnancies were randomized to daily treatment with progesterone or placebo pessaries from 20-24 weeks until 34 weeks' gestation. This subpopulation… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 29 references

Prevention of preterm delivery in twin gestations ( PREDICT ) : a multicenter , randomized , placebo - controlled trial on the effect of vaginal micronized progesterone

  • CP Durnwald, V Momirova, +12 authors CY Spong
  • Ultrasound Obstet Gynecol
  • 2011

Progesterone in high-risk twins

  • EA DeFranco, JM O’Brien, +22 authors GW. Creasy
  • Copyright  2011 ISUOG. Published by John Wiley…
  • 2011

Similar Papers

Loading similar papers…